Bhagiradha Chemicals & Industries Limited (BHAGCHEM)
Intimation of Credit Rating assigned to wholly owned subsidiary company i.e. Bheema Fine Chemicals Private Limited
Credit rating assigned to wholly owned subsidiary Bheema Fine Chemicals Private Limited
- Bank loan facilities rated IND BBB+/Stable and IND A2+ by India Ratings
- Rating reflects strong strategic, operational, and financial linkages with parent Bhagiradha Chemicals
- Ongoing 9,000 mtpa capacity expansion to increase group capacity to 12,250 mtpa
- Consolidated revenue and EBITDA expected to improve over FY27-FY28 with ramp-up of new facility
- Elevated net leverage due to debt-funded capex; liquidity supported by working capital facilities and moratorium
- Key risks: working capital intensity, product concentration, regulatory risks in agrochemical industry
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 BHAGCHEM — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add BHAGCHEM to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Bhagiradha Chemicals & Industries Limited
Important.
The summary above is generated automatically from Bhagiradha Chemicals & Industries Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.